Wisconsin uni to pay $32 million for withholding Zemplar royalties
St. Louis-based Washington University has won more than $31.6 million from a patent victory over the University of Wisconsin’s technology transfer office.
3M settles mask price-gouging suit with ex-Marine
A Minnesota judge has approved an agreement between 3M and a former Marine, resolving a price-gouging dispute over N95 masks.
Cozen O'Connor snaps up Kilpatrick Townsend duo
Cozen O’Connor has hired Jeffrey Gendzwill and Keith Fredlake from Kilpatrick Townsend & Stockton into the firm’s Washington, DC office.
LSPN Connect: Eldora Ellison on PTAB denials, CRISPR and section 101
Discretionary denials at the Patent Trial and Appeal Board, the CRISPR landscape and section 101 are top of mind for Eldora Ellison, director at Sterne Kessler Goldstein & Fox.
Bayer to spend up to $4bn on Asklepios BioPharmaceutical
Germany-based Bayer will pay up to $4 billion to acquire gene therapy company Asklepios BioPharmaceutical.
Canada's drug pricing plan prompts backlash
The final version of guidelines issued by Canada’s federal drug price regulator last week has caused uproar among the pharma industry.
English court resumes Amgen cholesterol patent suit
The English High Court has lifted a stay on Amgen’s lawsuit which accused Sanofi-Aventis and Regeneron of infringing a patent covering pharmaceuticals which treat elevated cholesterol levels.
Roche secures rights to potential COVID-19 drug
Swiss pharmaceutical company Roche will pay $350 million for the rights to develop and distribute an investigational COVID-19 antiviral outside of the US.
Eli Lilly’s Dermira accuses Perrigo of infringing patents
Pharmaceutical company Eli Lilly’s subsidiary Dermira has accused generic drugmaker Perrigo of infringing eight patents for Qbrexza, a prescription-only cloth towelette approved to treat hyperhidrosis, a condition that causes excessive underarm sweating.
Seagen targets Daiichi in cancer drug suit
US biotechnology company Seagen has accused Japanese pharmaceutical company Daiichi Sankyo of infringing patents with a recently-approved breast cancer drug.
